The E-tegrity Test

Importance Of The E-tegrity Test

The E-tegrity test is used to evaluate the receptivity of endometrial tissue for the treatment of unexplained infertility. Fertility treatments cause stress and anxiety, particularly when the cause is not known. The E-tegrity test is performed after endometrial biopsy and can help identify the reason behind the fertility problems to help determine the most appropriate infertility treatment options for the individual patient.

For this test, an endometrial biopsy is used to evaluate the presence of Beta-3 integrin, a protein that is needed for the fertilized egg to successfully implant in the in vitro fertilization process. Without the presence of this protein, infertility treatments are more likely to fail, causing distress and frustration.

Studies have shown that women with endometriosis lack the Beta-3 integrin, which contributes to the link between endometriosis and infertility. Endometriosis occurs when the uterine lining grows outside the uterus. The exact endometriosis causes are not known, but the condition is believed to be related to problems with the menstrual flow. Endometriosis treatment options include surgery and medicine and the appropriate treatment will depend on endometriosis stages. Accurate endometriosis diagnosis is essential to provide treatment as early as possible to avoid more damage, which can lead to pregnancy and fertility problems.

Information For Women & Families
Information For Physicians

Since there is no infertility cure, women need to work closely with their doctors to determine the best female infertility treatment path for their individual situation. An endometrial biopsy and testing for the Beta-3 integrin can help avoid in vitro fertilization failure and improve the outcomes for endometriosis and achieving pregnancy. Often, this simple test can provide valuable information for the effective treatment of infertility.